AR095265A1 - Procesos para la preparación de un agente inductor de la apoptosis - Google Patents
Procesos para la preparación de un agente inductor de la apoptosisInfo
- Publication number
- AR095265A1 AR095265A1 ARP140100877A ARP140100877A AR095265A1 AR 095265 A1 AR095265 A1 AR 095265A1 AR P140100877 A ARP140100877 A AR P140100877A AR P140100877 A ARP140100877 A AR P140100877A AR 095265 A1 AR095265 A1 AR 095265A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- preparation
- processes
- formulas
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 abstract 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 abstract 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical class CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/10—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un proceso para la preparación de un agente inductor de la apoptosis, y sustancias químicas intermediarias del mismo. También, sustancias químicas intermediarias relacionadas con dicho proceso. Reivindicación 1: Un proceso para la preparación de un compuesto de la fórmula (1), donde R² se selecciona entre los restos de fórmulas (2) y (3); caracterizado porque comprende: (a) combinar un compuesto de la fórmula (4) donde R es alquilo C₁₋₁₂, con una sal tert-butóxido, un solvente orgánico aprótico, y agua para proveer un compuesto de la fórmula (5); y (b) combinar el compuesto de la fórmula (5) con clorhidrato de 1-etil-3-(3-dimetilaminopropil)carbodiimida, 4-dimetilaminopiridina, un solvente orgánico, y ya sea un compuesto de la fórmula (6), para proveer un compuesto de la formula (1) donde R² es el resto de fórmulas (2); o un compuesto de la fórmula (7), para proveer un compuesto de la fórmula (1) donde R² es el resto de fórmulas (3) para proveer de esa manera un compuesto de la fórmula (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780621P | 2013-03-13 | 2013-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095265A1 true AR095265A1 (es) | 2015-09-30 |
Family
ID=51530141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100877A AR095265A1 (es) | 2013-03-13 | 2014-03-12 | Procesos para la preparación de un agente inductor de la apoptosis |
Country Status (2)
Country | Link |
---|---|
US (2) | US9006438B2 (es) |
AR (1) | AR095265A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102158467B1 (ko) | 2012-09-07 | 2020-09-25 | 제넨테크, 인크. | Ii형 항-cd20 항체와 선택적 bcl-2 억제제와의 병용 치료요법 |
US9238652B2 (en) | 2014-03-04 | 2016-01-19 | Abbvie Inc. | Processes for the preparation of an apoptosis-inducing agent |
US11533177B2 (en) * | 2015-03-13 | 2022-12-20 | United States Postal Service | Methods and systems for data authentication services |
US10645068B2 (en) | 2015-12-28 | 2020-05-05 | United States Postal Service | Methods and systems for secure digital credentials |
US11001582B2 (en) * | 2016-03-10 | 2021-05-11 | Assia Chemical Industries Ltd. | Solid state forms of Venetoclax and processes for preparation of Venetoclax |
EP3468973A4 (en) * | 2016-06-09 | 2020-02-26 | Dr. Reddy's Laboratories Ltd. | SOLID FORMS OF VENETOCLAX AND METHOD FOR PRODUCING VENETOCLAX |
WO2018069941A2 (en) * | 2016-10-14 | 2018-04-19 | Mylan Laboratories Limited | Polymorphic forms of venetoclax |
EP3333167A1 (en) * | 2016-12-09 | 2018-06-13 | LEK Pharmaceuticals d.d. | Solid forms of venetoclax |
CN110546151B (zh) | 2017-04-18 | 2023-04-28 | 重庆复创医药研究有限公司 | 凋亡诱导剂 |
EP3412666A1 (en) * | 2017-06-07 | 2018-12-12 | Albany Molecular Research, Inc. | Process and intermediates for the preparation of bcl-2 inhibitors including venetoclax through reductive amination |
WO2018225043A1 (en) * | 2017-06-10 | 2018-12-13 | Lupin Limited | Solid state forms of an apoptosis-inducing agent and processes thereof |
US20220259204A1 (en) * | 2019-07-12 | 2022-08-18 | Natco Pharma Limited | A process for the preparation of venetoclax and its polymorphs thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005049593A2 (en) | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
HUE027698T2 (en) | 2009-05-26 | 2016-10-28 | Abbvie Bahamas Ltd | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
US9034875B2 (en) | 2009-05-26 | 2015-05-19 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
TWI520960B (zh) | 2010-05-26 | 2016-02-11 | 艾伯維有限公司 | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑 |
CA3152557A1 (en) | 2010-10-29 | 2012-05-03 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
JP6141188B2 (ja) | 2010-11-23 | 2017-06-07 | アッヴィ・インコーポレイテッド | アポトーシス誘導剤の塩および結晶の形態 |
-
2014
- 2014-03-12 AR ARP140100877A patent/AR095265A1/es unknown
- 2014-03-12 US US14/207,179 patent/US9006438B2/en active Active
-
2015
- 2015-03-11 US US14/644,970 patent/US9199992B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9199992B2 (en) | 2015-12-01 |
US20150183783A1 (en) | 2015-07-02 |
US20140275540A1 (en) | 2014-09-18 |
US9006438B2 (en) | 2015-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR095265A1 (es) | Procesos para la preparación de un agente inductor de la apoptosis | |
PE20151809A1 (es) | Procesos para la preparacion de un agente inductor de la apoptosis | |
AR093759A1 (es) | Dihidropiridona p1 como inhibidores del factor xia | |
AR098912A1 (es) | Inhibidores de syk | |
CU20160052A7 (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
CU24517B1 (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos | |
AR101729A1 (es) | Compuestos que inhiben la proteína mcl-1 | |
AR100006A1 (es) | Derivados de tubulisina | |
CR20160098A (es) | Polimorfo de los inhibidores de la syk | |
AR091273A1 (es) | Inhibidores de pirimidinil tirosina quinasa | |
AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
AR101690A1 (es) | Composiciones tensioactivas acuosas | |
AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
AR095443A1 (es) | Heterociclos condensados con acción sobre atr | |
AR094553A1 (es) | Formas de oxadiazolpirazina | |
AR100333A1 (es) | Derivados de heterociclil-butanamida | |
AR110119A1 (es) | Proceso para la purificación de pirazolpiridazinas | |
AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
AR097739A1 (es) | Imidazo[1,2-a]piridina-7-aminas | |
AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
AR093841A1 (es) | Compuestos azaheterobiciclicos | |
AR072880A1 (es) | Derivados nitrogenados de la pancratistatina | |
AR102246A1 (es) | Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis, usos | |
AR104539A1 (es) | Compuestos cíclicos | |
AR096552A1 (es) | Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |